| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBAMEM.2010.03.005 |
| P698 | PubMed publication ID | 20214875 |
| P50 | author | Ülo Langel | Q47087785 |
| Sébastien Deshayes | Q59545218 | ||
| P2093 | author name string | Gilles Divita | |
| Emelía Eiríksdóttir | |||
| Karidia Konate | |||
| P433 | issue | 6 | |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1119-1128 | |
| P577 | publication date | 2010-03-07 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Secondary structure of cell-penetrating peptides controls membrane interaction and insertion | |
| P478 | volume | 1798 |
| Q64993130 | A Comprehensive Review on Current Advances in Peptide Drug Development and Design. |
| Q62513048 | A Novel Cell Penetrating Peptide for the Differentiation of Human Neural Stem Cells |
| Q37034573 | A common landscape for membrane‐active peptides |
| Q36894985 | A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells |
| Q47236927 | A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases |
| Q30847307 | A retro-inverso cell-penetrating peptide for siRNA delivery. |
| Q92071340 | Abiotic Factors Promote Cell Penetrating Peptide Permeability in Enterobacteriaceae Models |
| Q35599319 | Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors |
| Q36763669 | An Intrinsically Disordered Peptide Facilitates Non-Endosomal Cell Entry |
| Q33811185 | An Unusual Cell Penetrating Peptide Identified Using a Plasmid Display-Based Functional Selection Platform |
| Q44840359 | Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4 |
| Q42018079 | CPPsite: a curated database of cell penetrating peptides |
| Q47547640 | Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. |
| Q35806512 | Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo |
| Q47586545 | Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity |
| Q34215571 | Cell-penetrating peptides: classes, origin, and current landscape |
| Q42807063 | Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure–activity relationship studies |
| Q34504889 | Characterization of a novel cell penetrating peptide derived from human Oct4. |
| Q61811330 | Cholesterol re-organisation and lipid de-packing by arginine-rich cell penetrating peptides: Role in membrane translocation |
| Q82635656 | Comparative study on the interaction of cell-penetrating polycationic polymers with lipid membranes |
| Q67403879 | De novo design of tunable, pH-driven conformational changes. |
| Q28477376 | Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles |
| Q92130284 | Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor |
| Q35785197 | Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier |
| Q35013447 | Dual peptide conjugation strategy for improved cellular uptake and mitochondria targeting |
| Q41936163 | Dynamic measurements of membrane insertion potential of synthetic cell penetrating peptides |
| Q54367878 | Effect of Point Mutations on the Secondary Structure and Membrane Interaction of Antimicrobial Peptide Anoplin |
| Q40575180 | Enhanced Cationic Charge is a Key Factor in Promoting Staphylocidal Activity of α-Melanocyte Stimulating Hormone via Selective Lipid Affinity |
| Q58741014 | Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery |
| Q38759934 | Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants |
| Q58564633 | Fluorescence Correlation Spectroscopy Reveals Efficient Cytosolic Delivery of Protein Cargo by Cell-Permeant Miniature Proteins |
| Q55020985 | Fluorophore labeling of a cell-penetrating peptide significantly alters the mode and degree of biomembrane interaction. |
| Q41590508 | Gene introduction into the mitochondria of Arabidopsis thaliana via peptide-based carriers |
| Q49787719 | Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery |
| Q39447373 | In silico approaches for designing highly effective cell penetrating peptides. |
| Q47621379 | In silico methods for design of biological therapeutics. |
| Q51150438 | In silico models for designing and discovering novel anticancer peptides |
| Q33577349 | Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers |
| Q46852605 | Internalization of flax rust avirulence proteins into flax and tobacco cells can occur in the absence of the pathogen |
| Q39590246 | Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism |
| Q54340249 | Investigation of self-assembling proline- and glycine-rich recombinant proteins and peptides inspired by proteins from a symbiotic fungus using atomic force microscopy and circular dichroism spectroscopy |
| Q35053052 | Killer bee molecules: antimicrobial peptides as effector molecules to target sporogonic stages of Plasmodium |
| Q64966698 | M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines. |
| Q58717273 | Membrane Active Peptides and Their Biophysical Characterization |
| Q38369494 | Modifications of natural peptides for nanoparticle and drug design |
| Q38714911 | Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects |
| Q38787773 | Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma. |
| Q26746968 | Peptides for nucleic acid delivery |
| Q38243361 | Peptides used in the delivery of small noncoding RNA. |
| Q33883945 | Physicochemical Mechanism for the Enhanced Ability of Lipid Membrane Penetration of Polyarginine |
| Q40363443 | SATPdb: a database of structurally annotated therapeutic peptides |
| Q47244197 | Secondary structure of cell-penetrating peptides during interaction with fungal cells |
| Q61736743 | Self-assembly dynamics and antimicrobial activity of all l- and d-amino acid enantiomers of a designer peptide |
| Q51736432 | Supramolecular self assembly of nanodrill-like structures for intracellular delivery |
| Q64991608 | TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier. |
| Q48269589 | The potent effect of mycolactone on lipid membranes. |
| Q39180140 | Transducing properties of a pre-structured α-helical DPT-peptide containing a short canine adenovirus type 2 E4orf4 PP2A1-binding sequence |
| Q64084500 | Transportan 10 improves the pharmacokinetics and pharmacodynamics of vancomycin |
| Q30840924 | Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study. |
| Q57031896 | Two Engineered OBPs with opposite temperature-dependent affinities towards 1-aminoanthracene |
Search more.